Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Trial to evaluate inhaled COVID-19 therapy finishes enrolment

europeanpharmaceuticalreviewJanuary 19, 2021

Tag: COVID-19 , PMDI , Ensifentrine

PharmaSources Customer Service